Filter content

With the COVID-19 pandemic making it harder for many individuals with substance use disorder to access care, the MetroHealth System in Cleveland is bringing resources to those individuals where they are.

Awakn Life Sciences has announced plans to conduct a Phase IIb trial to study MDMA-assisted psychotherapy as a treatment for patients with alcohol use disorder, with PRA Health Sciences as the contract research organization for the project.

HHS on Thursday announced that it will publish new guidelines that will expand access to medication-assisted treatment for opioid use disorder by exempting physicians from certain certification requirements necessary for prescribing buprenorphine.

Findings in a Phase III clinical trial released by NIH showed that a combination of two medications—injectable naltrexone and oral bupropion—were safe and effective in the treatment of adults with moderate or severe methamphetamine use disorder. Results of the study, which was conducted at…

Results of a NIDA-supported pilot study released on Monday showed that collaboration between physicians and pharmacists could lead to improved medication adherence among patients being treated for opioid use disorder.

With more than 40 states reporting an increase in overdose deaths during the COVID-19 pandemic, the American Medical Association, in partnership with the firm Manatt Health, has published an update to its National Roadmap on State-Level Efforts to End the Nation’s Drug Overdose Epidemic.

Methamphetamine use—both on its own and in combination with other substances—is on the rise, according to data from a recent study by specialty laboratory Millennium Health. Results from the study were published in the Journal of Addiction Medicine.

Spark Biomedical, a Texas-based medical device company, announced this week that the FDA has granted 510(k) clearance for its Sparrow Therapy System, a wearable neurostimulation device for the treatment of opioid withdrawal. With FDA clearance obtained, the Sparrow system is now available to U.S.…

Recent provisional data from the Centers for Disease Control and Prevention indicate that about 81,230 drug overdose deaths occurred in the U.S. between June 2019 and May 2020—the highest number of overdose deaths in a 12-month period in U.S. history. During that period, overdose deaths increased…

Despite recommendations last June from an advisory committee, the latest edition of the Dietary Guidelines for Americans, jointly released by the federal departments of Agriculture and Health and Human Services, maintain the guidance on alcohol consumption found in previous versions of the document.